Aspen Pharmacare (APNHY) Stock Price, News & Analysis

Company Overview

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Key Stats

• Today's Range: $6.71 to $6.71
• 50-Day Range: $5.98 to $9.92
• 52-Week Range: $5.76 to $13.69
• Volume: 188 shs
• Average Volume: 1,273 shs
• Market Capitalization: $2.99 billion
• P/E Ratio: N/A
• Dividend Yield: 1.79%
• Price Target: N/A
• Consensus Rating: N/A

APNHY Stock Analysis - Frequently Asked Questions

How have APNHY shares performed this year?

Aspen Pharmacare's stock was trading at $8.26 at the beginning of 2025. Since then, APNHY stock has decreased by 18.8% and is now trading at $6.71.
View the best growth stocks for 2025 here.

How do I buy shares of Aspen Pharmacare?

Shares of APNHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/27/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:APNHY
• Previous Symbol: NASDAQ:APNHY
• CIK: 1454177
• Web: www.aspenpharma.com
• Phone: (731) 580-8600
• Fax: 27-11-239-6144
• Employees: 9,350
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.30
• Current Ratio: 1.81
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $2.39 billion
• Price / Sales: 1.25
• Cash Flow: $0.77 per share
• Price / Cash Flow: 8.74
• Book Value: $10.90 per share
• Price / Book: 0.62

Miscellaneous

• Outstanding Shares: 446,250,000
• Free Float: N/A
• Market Cap: $2.99 billion
• Optionable: Not Optionable
• Beta: 1.03